Clinical Trial Update: The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating oral 9-cis rich powder of Dunaliella bardawil for visual function in adolescent patients with Retinitis Pigmentosa;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• 9-cis rich powder of Dunaliella bardawil

Snippet

Sponsor: Sheba Medical Center | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING